Sheel Biotech Limited
IPO Details
Subscription
Lot Distribution
Reservation
Company Fin.
₹15(23.81%)
Premium (ELP)
Having completed its public offering, Sheel Biotech Limited's is now listed and trading on the NSE exchange as of Oct 08, 2025. The IPO raised cumulative capital of 54,00,000 Shares, including 54,00,000 Shares in primary capital infusion.
The IPO was conducted with a price range of ₹59 to ₹63 and minimum investment requirement of 2000 shares. subscription activity between Sep 30, 2025 and Oct 03, 2025 reflected market assessment of the offering's valuation and prospects.
The allotment process finalized on Oct 06, 2025 distributed equity ownership to successful bidders. The listing established a transparent market mechanism for share trading, price discovery, and investor participation in the company's future growth.
Investors can bid starting from the minimum lot size specified for this IPO, and only in multiples of that lot size. The table below shows the minimum and maximum investment for retail investors and HNIs in terms of lots, quantity, and amount.
Sheel Biotech Limited, incorporated in November 1991, specializes in biotechnology, floriculture, greenhouses, and organic farming. The company produces high-quality, disease-free plants for fruits, vegetables, ornamentals, and field crops using tissue culture and hydroponics, and provides greenhouse manufacturing, farmer services, and training through FPOs. It also offers landscaping services to government and private clients and holds ISO certifications for quality, environment, and safety. Its R&D lab is recognized by India’s Department of Biotechnology and Department of Science and Technology. Sheel Biotech supports organic farming adoption, manages FPOs, implements turnkey horticultural projects with modern technologies, and conducts training programs for farmers and agripreneurs. As of September 30, 2024, it had 160 permanent employees.
Note : "Calculations for ‘Shares Offered’ and ‘Total Amount’ are based on the highest price in the issue price band."
- Biotechnology and Greenhouse Expertise: Skilled in tissue culture, organic farming, and modern horticultural technologies.
- Wide Product and Service Range: Offers planting materials, turnkey greenhouse projects, organic certification, FPO support, and training.
- Sustainability and Recognition: Follows eco-friendly practices and holds government-recognized R&D and international quality, safety, and environmental certifications.
- Strict Precision in Tissue Culture: Lapses in sterilization, storage, or temperature control can lead to contamination and significant losses.
- Dependence on Government Tenders: Revenue from organic farming heavily relies on winning tenders, making it vulnerable to policy or tender changes.
- Operational Risks in Production: Small errors in tissue culture processes can disrupt the entire production cycle.
- Dr. Satya Narayan Chandak
- Mr. Sanjay Chandak
- Mr. Divye Chandak
- Mrs. Mini Chadha
- M/s Satya Narayan Chandak (HUF)
- M/s Sanjay Chandak (HUF)
- M/s Sumeet Chandak (HUF)
Sheel Biotech Limited
Skyline Financial Services Private Limited